![biotech_employer_img](/_next/image?url=%2Fimages%2Fworking_process_shap.png&w=3840&q=75)
![edit_profile](https://production-biostaffic-media.s3.amazonaws.com/company-logos/Avalyn-Pharma-Inc-.png)
Avalyn Pharma Inc.
United States
Member Since:Jan 31, 2024
Ownership:N/A
Number of Offices:N/A
Total Employees:11-50
Established In:N/A
Avalyn is a clinical-stage biopharmaceutical company developing inhaled therapies to treat rare respiratory diseases, including idiopathic pulmonary fibrosis and other interstitial lung diseases. Our lead candidate, AP01, is a Phase 2b-ready inhaled formulation of pirfenidone in development for the treatment of pulmonary fibrosis
No record available!
No record available!
No record available!
No record available!
No record available!
No record available!